“EPIDEMIOLOGICAL INVESTIGATION AND CLINICAL MANAGEMENT FOR THE TREATMENT OF EPILEPSY”, Journal of Pharmaceutical Negative Results, pp. 6432–6441, Dec. 2022, doi: 10.47750/pnr.2022.13.S09.765.